MagForce is forging new paths to treat cancer successfully and gently. With NanoTherm® Therapy System (NTTS), we have developed an innovative approach based on nanotechnology, which we want to make available to patients worldwide. And we are getting closer and closer to this goal. NTTS is the first and only nanotechnology-based therapy with European approval for treating recurrent Glioblastoma, a deadly brain tumor. To date, many patients diagnosed with Glioblastoma tumors have improved their quality of life after using our technology.
| Website | http://www.magforce.de |
| Ticker | FRA:MF6 |
| Revenue | $17 million |
| Employees | 37 (12 on RocketReach) |
| Founded | 1997 |
| Address | 3 Max-planck-strasse, Berlin, Berlin 12489, DE |
| Phone | +49 4930 3083800 |
| Industry | Medical Equipment Manufacturing, Manufacturing General, Health Care, Manufacturing, Medical Device, Nanotechnology, Science and Engineering |
| Keywords | Therapeutics, Nanotechnology, Cancer Treatment, Nanomedicine, Precision Medicine, Oncology, Medical Technology, Cancer Therapy, Thermal Therapy, Healthcare Technology, Biotechnology, Medical Devices, Drug Delivery, Targeted Therapy, Cancer Research, Clinical Trials, Pharmaceutical |
| Competitors | Siemens Healthineers, GE HealthCare, Medtronic, Abbott, Bayer, Philips, Merck Group, Teleflex, Varian, Fresenius Group +45 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies |
Looking for a particular MagForce AG employee's phone or email?
MagForce AG Questions
The MagForce AG annual revenue was $17 million in 2026.
Junaed Ahamed is the COO of MagForce AG.
12 people are employed at MagForce AG.
MagForce AG is based in Berlin, Berlin.
The NAICS codes for MagForce AG are [33, 334].
The SIC codes for MagForce AG are [38, 384].
Top MagForce AG Employees
